Volume | 21,009 |
|
|||||
News | - | ||||||
Day High | 2.5412 | Low High |
|||||
Day Low | 2.37 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
DiaMedica Therapeutics Inc | DMAC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.47 | 2.37 | 2.5412 | 2.39 | 2.49 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
168 | 21,009 | $ 2.44 | $ 51,304 | - | 1.50 - 4.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 100 | $ 2.39 | USD |
DiaMedica Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
90.71M | 37.95M | - | 0 | -13.68M | -0.36 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
DiaMedica Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DMAC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.54 | 2.635 | 2.29 | 2.47 | 32,137 | -0.15 | -5.91% |
1 Month | 2.67 | 3.34 | 2.29 | 2.71 | 54,514 | -0.28 | -10.49% |
3 Months | 2.69 | 3.34 | 2.29 | 2.86 | 41,592 | -0.30 | -11.15% |
6 Months | 2.12 | 3.34 | 2.05 | 2.71 | 46,181 | 0.27 | 12.74% |
1 Year | 1.72 | 4.75 | 1.50 | 3.11 | 79,740 | 0.67 | 38.95% |
3 Years | 9.36 | 9.937 | 1.12 | 3.45 | 109,271 | -6.97 | -74.47% |
5 Years | 3.40 | 10.88 | 1.12 | 4.38 | 101,513 | -1.01 | -29.71% |
DiaMedica Therapeutics Description
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. |